BPIFB4 has been shown to serve as a biomarker of healthy aging (15,16) and previous finding on its prognostic significance in vascular pathology (ie, atherosclerotic patients) (18), prompted us to examine BPIFB4 contribution in COVID-19. Here, BPIFB4 is linked to COVID-19.